Workflow
icon
Search documents
艾美疫苗:Strategic Leadership Amid Changes in China's Vaccine Market Supply and Demand Dynamics
复星国际证券· 2025-01-22 13:14
Initiation | AIM Vaccine (6660.HK) Initiating Coverage Report January 21, 2025 | Price (20 Jan 2025) | HK$5.57 | | --- | --- | | Target Price (31 Jan 2026) | HK$11.0 | | Expected share price return | 97.7% | | Market Cap | HK$67,46M | Price Performance (6660.HK) Research Department, Fosun International Securities Limited research@fosunwealth.com AIM Vaccine (6660.HK): Strategic Leadership Amid Changes in China's Vaccine Market Supply and Demand Dynamics AIM Vaccine (6660.HK) stands out as a leading, full-in ...